ZOPRON

Serial Number 90400854
606

Registration Progress

Application Filed
Dec 22, 2020
Under Examination
Dec 21, 2021
Approved for Publication
Oct 26, 2021
Published for Opposition
Oct 26, 2021
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ZOPRON
Previous Owner: AZURITY PHARMACEUTICALS, INC.
Classes: 005

Trademark Image

ZOPRON

Basic Information

Serial Number
90400854
Filing Date
December 22, 2020
Published for Opposition
October 26, 2021
Abandonment Date
January 27, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 27, 2025
Classes
005

Rights Holder

AZURITY PHARMACEUTICALS, INC.

03
Address
8 CABOT ROAD, SUITE 2000
WOBURN, MA 01801

Ownership History

Eton Pharmaceuticals, Inc.

Original Applicant
03
Deer Park, IL

AZURITY PHARMACEUTICALS, INC.

New Owner Before Publication #1
03
WOBURN, MA

AZURITY PHARMACEUTICALS, INC.

Owner at Publication
03
WOBURN, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

40 events
Date Code Type Description Documents
Jan 27, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 27, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 30, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 29, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 29, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 26, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 26, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 6, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 6, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 26, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 24, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 24, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 24, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 25, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 21, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 26, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 26, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 6, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 22, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 21, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 21, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 21, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 19, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 19, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 19, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 18, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 8, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 8, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 8, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 7, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 3, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 25, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention of seizures or epilepsy; Pharmaceutical compositions for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical formulations for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical formulations and compositions containing zonisamide for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical preparations for the treatment of seizures or epilepsy

Classification

International Classes
005